poisar

Stock

Clene Inc. CLNN

$4.14-1.19%

Overview

CLNN market data

Price History

CLNN price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$2.65
Diluted earnings per share over the trailing twelve months.
Beta
0.91
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-25,009.7%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$3.50 – $13.50
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $65.9M · P/B 2.84 · P/S 492.06.

Company News

2 captured
8-K filing — Clene Inc. (CLNN)SEC EDGAR · Aug 14, 2026, 12:35 PM
Clene Says Post Hoc Analyses Show CNM-Au8-Treated ALS Patients With NfL Decline Or Stabilization Had 38% Lower Risk Of Death vs. Controls In HEALEY; NDA Planned For Early Q4Benzinga · Aug 10, 2026, 12:06 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock